Prescription Drug Pricing

Why Are Patient Groups Silent on High Drug Prices?

By NWHN Staff | Apr 10, 2020 | Comments Off on Why Are Patient Groups Silent on High Drug Prices?

NWHN Executive Director Cynthia Pearson is quoted in an article discussing the silence of patient advocacy groups in regards to high drug prices.

Don’t Hate the Player, Hate the Game: Drug Pricing in America

By NWHN Staff | Mar 14, 2016 | Comments Off on Don’t Hate the Player, Hate the Game: Drug Pricing in America

Prescription drug price increases are incredibly common in the United States, with some drugs experiencing multiple price increases in a single year.

Hepatitis Drugs and Skyrocketing Health Care Costs

By Charlea T. Massion, MD, and Adriane Fugh-Berman, MD | Jan 6, 2016 | Comments Off on Hepatitis Drugs and Skyrocketing Health Care Costs

U.S. drug prices are out of control and unsustainable. We’re the only developed country where public programs cannot negotiate drug prices with pharmaceutical manufacturers; as a result, the U.S. generally pays more for branded prescription drugs than any other country.